Ioannis Stouras: Why PD-L1 CPS Remains Key in Head and Neck Cancer Immunotherapy
Ioannis Stouras/LinkedIn

Ioannis Stouras: Why PD-L1 CPS Remains Key in Head and Neck Cancer Immunotherapy

Ioannis Stouras, Associate Researcher National and Kapodistrian University of Athens, shared on X:

“Why hasn’t any new biomarker complemented PD-L1 CPS in head and neck cancer immunotherapy?

Our answer, born out of my PhD, is now out in Cancer Treatment Reviews.”

Title: Tissue and blood-based biomarkers of immunotherapy response in head and neck Cancer

Authors: Ioannis Stouras, Evangelos Zazas, Maria Cossu Rocca, Mohssen Ansarin, Amanda Psyrri

Read the Full Article

You may also be interested in:

Ioannis Stouras: Why PD-L1 CPS Remains Key in Head and Neck Cancer Immunotherapy